BioSpace News Archive

AbbVie announced that the European Commission has approved VENCLYXTO® in combination with a hypomethylating agent, azacitidine or decitabine, for the treatment of adult patients with newly diagnosed acute myeloid leukemia who are ineligible for intensive chemotherapy.1 The approval is valid in all 27 member states of the EU, as well as Iceland, Liechtenstein, and Norway.

The award from CDMRP will help fund the investigational new drug enabling toxicology studies for the company’s PIKFYVE-targeting drug candidate for ALS

Breadth of data presented demonstrates AbbVie’s longstanding commitment to develop a portfolio of solutions that advance standards of care for people living with rheumatic diseases

Heska Corporation, a leading global provider of advanced veterinary diagnostic and specialty products, announced that Kevin Wilson, Heska’s President and Chief Executive Officer, will present at the following conferences in June 2021:

Lifebit’s precision medicine software will power Hong Kong’s development of genomic medicine by supporting the Hong Kong Genome Institute to implement the first large-scale genome sequencing initiative, the Hong Kong Genome Project.

Agreement aims to accelerate development of a unique testosterone treatment for inflammatory breast diseases and estrogen-receptor positive breast cancer

Ardelyx, Inc., a biopharmaceutical company focused on developing innovative first-in-class medicines to improve treatment for people with kidney and cardiorenal diseases, announced that Mike Raab, president and chief executive officer of Ardelyx, will participate in a fireside chat at the Jefferies Virtual Healthcare Conference on Tuesday, June 1, 2021 at 3:30 p.m. ET.

Today, Federal Circuit Judge William C. Bryson, a Senior Circuit Judge of the U.S. Court of Appeals for the Federal Circuit, sitting by designation in the U.S. District Court for the District of Delaware, granted Clarus’s motion for summary judgment against Lipocine, Inc. (“Lipocine"; NASDAQ: LPCN)

My Personal Therapeutics Ltd. (trading as Vivan Therapeutics), a UK-based company, announces an expansion of its licensed technology rights from Mount Sinai Health System.

Surgery Partners, Inc., a leading provider of surgical services, announced that Wayne DeVeydt, Executive Chairman of the Board and Tom Cowhey, Chief Financial Officer will meet with investors at the Jefferies Virtual Healthcare Conference, including a presentation on Wednesday, June 2, 2021 at 3:30p.m.